Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsAntios Therapeutics, Inc. and Arbutus Biopharma Corporation announced that the first patient has been dosed in a triple combination treatment in patients with chronic hepatitis B virus infection.
[Antios Therapeutics, Inc.]
Home Newsletters Hepatic Cell News Antios Therapeutics and Arbutus Biopharma Announce First Patient Dosed in Phase IIa...
